Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage.

Frémond ML, Legendre M, Fayon M, Clement A, Filhol-Blin E, Richard N, Berdah L, Roullaud S, Rice GI, Bondet V, Duffy D, Sileo C, Ducou le Pointe H, Begueret H, Coulomb A, Neven B, Amselem S, Crow Y, Nathan N.

Thorax. 2020 Jan;75(1):92-95. doi: 10.1136/thoraxjnl-2019-213892. Epub 2019 Oct 30.

PMID:
31666386
2.

Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances.

Enaud R, Hooks KB, Barre A, Barnetche T, Hubert C, Massot M, Bazin T, Clouzeau H, Bui S, Fayon M, Berger P, Lehours P, Bébéar C, Nikolski M, Lamireau T, Delhaes L, Schaeverbeke T.

J Clin Med. 2019 May 10;8(5). pii: E645. doi: 10.3390/jcm8050645.

3.

Health-related quality of life in infants and children with interstitial lung disease.

Lauby C, Boelle PY, Abou Taam R, Bessaci K, Brouard J, Dalphin ML, Delacourt C, Delestrain C, Deschildre A, Dubus JC, Fayon M, Giovannini-Chami L, Houdouin V, Houzel A, Marguet C, Pin I, Reix P, Renoux MC, Schweitzer C, Tatopoulos A, Thumerelle C, Troussier F, Wanin S, Weiss L, Clement A, Epaud R, Nathan N.

Pediatr Pulmonol. 2019 Jun;54(6):828-836. doi: 10.1002/ppul.24308. Epub 2019 Mar 13.

PMID:
30868755
4.

CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis.

Refait J, Macey J, Bui S, Fayon M, Berger P, Delhaes L, Laurent F, Dournes G.

J Cyst Fibros. 2019 Jul;18(4):e31-e36. doi: 10.1016/j.jcf.2019.02.002. Epub 2019 Feb 12.

PMID:
30765182
5.

Variability of ciprofloxacin pharmacokinetics in children: impact on dose range in sickle cell patients.

Facchin A, Bui S, Leroux S, Nacka F, Koehl B, Maksoud E, Fayon M, Jacqz-Aigrain E; with the assistance of the Paediatric Clinical Investigation Centres Pharmacology Group.

J Antimicrob Chemother. 2018 Dec 1;73(12):3423-3429. doi: 10.1093/jac/dky328.

PMID:
30203024
6.

Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort.

Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, Couderc L, Donnou MD, Pagnier A, Blanchon S, Faure N, Mely L, Albertini M, de Blic J, Giovannini-Chami L.

Pediatr Pulmonol. 2018 Dec;53(12):1640-1650. doi: 10.1002/ppul.24089. Epub 2018 Jun 26.

PMID:
29943913
7.

Pulmonary hemosiderosis in children with Down syndrome: a national experience.

Alimi A, Taytard J, Abou Taam R, Houdouin V, Forgeron A, Lubrano Lavadera M, Cros P, Gibertini I, Derelle J, Deschildre A, Thumerelle C, Epaud R, Reix P, Fayon M, Roullaud S, Troussier F, Renoux MC, de Blic J, Leyronnas S, Thouvenin G, Perisson C, Ravel A, Clement A, Corvol H, Nathan N; French RespiRare® group.

Orphanet J Rare Dis. 2018 Apr 20;13(1):60. doi: 10.1186/s13023-018-0806-6.

8.

Remodelling and inflammation in preschoolers with severe recurrent wheeze and asthma outcome at school age.

Lezmi G, Deschildre A, Abou Taam R, Fayon M, Blanchon S, Troussier F, Mallinger P, Mahut B, Gosset P, de Blic J.

Clin Exp Allergy. 2018 Jul;48(7):806-813. doi: 10.1111/cea.13143. Epub 2018 May 7.

PMID:
29603800
9.

The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis.

Enaud R, Vandenborght LE, Coron N, Bazin T, Prevel R, Schaeverbeke T, Berger P, Fayon M, Lamireau T, Delhaes L.

Microorganisms. 2018 Mar 9;6(1). pii: E22. doi: 10.3390/microorganisms6010022. Review.

10.

Montelukast reverses airway remodeling in actively sensitized young mice.

Debelleix S, Siao-Him Fa V, Begueret H, Berger P, Kamaev A, Ousova O, Marthan R, Fayon M.

Pediatr Pulmonol. 2018 Jun;53(6):701-709. doi: 10.1002/ppul.23980. Epub 2018 Mar 1.

PMID:
29493871
11.

Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.

Gominon AL, Frison E, Hiriart JB, Vergniol J, Clouzeau H, Enaud R, Bui S, Fayon M, de Ledinghen V, Lamireau T.

J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):455-460. doi: 10.1097/MPG.0000000000001822.

PMID:
29112089
12.

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators.

Pranke IM, Hatton A, Simonin J, Jais JP, Le Pimpec-Barthes F, Carsin A, Bonnette P, Fayon M, Stremler-Le Bel N, Grenet D, Thumerel M, Mazenq J, Urbach V, Mesbahi M, Girodon-Boulandet E, Hinzpeter A, Edelman A, Sermet-Gaudelus I.

Sci Rep. 2017 Aug 7;7(1):7375. doi: 10.1038/s41598-017-07504-1.

13.

Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.

Coron N, Pihet M, Fréalle E, Lemeille Y, Pinel C, Pelloux H, Gargala G, Favennec L, Accoceberry I, Durand-Joly I, Dalle F, Huet F, Fanton A, Boldron A, Loeuille GA, Domblides P, Coltey B, Pin I, Llerena C, Troussier F, Person C, Marguet C, Wizla N, Thumerelle C, Turck D, Bui S, Fayon M, Duhamel A, Prévotat A, Wallaert B, Leroy S, Bouchara JP, Delhaes L.

Mycopathologia. 2018 Feb;183(1):101-117. doi: 10.1007/s11046-017-0173-1. Epub 2017 Jul 26.

PMID:
28748285
14.

Altered pulmonary gas transfer capacity and capillary blood volume in pediatric Crohn's disease.

Verstraete M, Choukroun ML, Siao-Him Fa V, Fayon M, Rebouissoux L, Enaud R, Lamireau T.

Pediatr Pulmonol. 2017 Aug;52(8):1051-1056. doi: 10.1002/ppul.23703.

PMID:
28719106
15.

Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis.

Dournes G, Berger P, Refait J, Macey J, Bui S, Delhaes L, Montaudon M, Corneloup O, Chateil JF, Marthan R, Fayon M, Laurent F.

Radiology. 2017 Oct;285(1):261-269. doi: 10.1148/radiol.2017162350. Epub 2017 May 22.

PMID:
28530849
16.

Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children.

Fayon M, Lacoste-Rodrigues A, Barat P, Helbling JC, Nacka F, Berger P, Moisan MP, Corcuff JB.

PLoS One. 2017 May 11;12(5):e0177051. doi: 10.1371/journal.pone.0177051. eCollection 2017.

17.

[Early lung disease in cystic fibrosis].

Fayon M, Ladipo Y, Galodé F, Debelleix S, Reix P.

Arch Pediatr. 2016 Dec;23(12S):12S9-12S14. doi: 10.1016/S0929-693X(17)30057-X. Review. French.

PMID:
28231896
18.

[New therapeutic developments in cystic fibrosis].

Bui S, Macey J, Fayon M; « nouvelles thérapeutiques de la Société Française pour la Mucoviscidose », Bihouée T, Burgel PR, Colomb V, Corvol H, Durieu I, Hubert D, Marguet C, Mas E, Munck A, Murris-Espin M, Reix P, Sermet-Gaudelus I.

Arch Pediatr. 2016 Dec;23(12S):12S47-12S53. doi: 10.1016/S0929-693X(17)30062-3. Review. French.

PMID:
28231894
19.

[New tools in cystic fibrosis].

Dournes G, De Boeck K, Bui S, Vermeulen F, Ramalho A, Chateil JF, Laurent F, Fayon M.

Arch Pediatr. 2016 Dec;23(12S):12S39-12S46. doi: 10.1016/S0929-693X(17)30061-1. Review. French.

PMID:
28231892
20.

Éditorial.

Bui S, Clouzeau H, Fayon M.

Arch Pediatr. 2016 Dec;23(12S):12S1. doi: 10.1016/S0929-693X(17)30053-2. French. No abstract available.

PMID:
28231888
21.

Respiratory Morbidity in Infants Born With a Congenital Lung Malformation.

Delestrain C, Khen-Dunlop N, Hadchouel A, Cros P, Ducoin H, Fayon M, Gibertini I, Labbé A, Labouret G, Lebras MN, Lezmi G, Madhi F, Thouvenin G, Thumerelle C, Delacourt C.

Pediatrics. 2017 Mar;139(3). pii: e20162988. doi: 10.1542/peds.2016-2988. Epub 2017 Feb 15.

22.

Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study.

Le Bourgeois M, Ferroni A, Leruez-Ville M, Varon E, Thumerelle C, Brémont F, Fayon MJ, Delacourt C, Ligier C, Watier L, Guillemot D; Children, Antibiotics, Nonsteroidal Anti-inflammatory Drugs and Childhood Empyema (ChANCE) Study Group.

J Pediatr. 2016 Aug;175:47-53.e3. doi: 10.1016/j.jpeds.2016.05.025. Epub 2016 Jun 20.

PMID:
27339249
23.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, Montaudon M, Berger P, Laurent F.

Radiology. 2016 Apr;279(1):328. doi: 10.1148/radiol.2016164006. No abstract available.

PMID:
26989938
24.

[Early lung disease in infants with cystic fibrosis. Diagnostic tools and possible therapeutic pathways].

Reix P, Matecki S, Fayon M.

Rev Mal Respir. 2016 Feb;33(2):102-16. doi: 10.1016/j.rmr.2015.06.017. Epub 2016 Feb 2. Review. French.

PMID:
26850625
25.

Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution.

Dournes G, Menut F, Macey J, Fayon M, Chateil JF, Salel M, Corneloup O, Montaudon M, Berger P, Laurent F.

Eur Radiol. 2016 Nov;26(11):3811-3820. Epub 2016 Feb 2.

PMID:
26843010
26.

Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment.

Giovannini-Chami L, Blanc S, Hadchouel A, Baruchel A, Boukari R, Dubus JC, Fayon M, Le Bourgeois M, Nathan N, Albertini M, Clément A, de Blic J.

Pediatr Pulmonol. 2016 Feb;51(2):203-16. doi: 10.1002/ppul.23368. Epub 2015 Dec 30. Review.

PMID:
26716396
27.

Evaluation of nutritional status and support in children with congenital heart disease.

Blasquez A, Clouzeau H, Fayon M, Mouton JB, Thambo JB, Enaud R, Lamireau T.

Eur J Clin Nutr. 2016 Apr;70(4):528-31. doi: 10.1038/ejcn.2015.209. Epub 2015 Dec 23.

PMID:
26695725
28.

Effectiveness of palivizumab in children with childhood interstitial lung disease: The French experience.

Drummond D, Thumerelle C, Reix P, Fayon M, Epaud R, Clement A, Mahloul M, Habouria D, Delacourt C, Hadchouel A.

Pediatr Pulmonol. 2016 Jul;51(7):688-95. doi: 10.1002/ppul.23354. Epub 2015 Dec 4.

PMID:
26636747
29.

[Prescription of asthma action plans in the Aquitaine region of France].

Eguienta S, Fayon M.

Rev Mal Respir. 2016 May;33(5):365-76. doi: 10.1016/j.rmr.2015.10.001. Epub 2015 Nov 3. French.

PMID:
26545450
30.

RECURRENCE OF POMPE DISEASE IN FIRST COUSINS.

Lacombe D, Thambo JB, Fayon M, Goizet C, Guffon N.

Genet Couns. 2015;26(2):227-31.

PMID:
26349193
31.

[Legal aspects of consent in children (Part 1)].

Nacka F, Benadjaoud L, Fayon M, Jacqz-Aigrain E; Membres du Réseau Pédiatrique Inserm des Centres d'investigations cliniques (CIC), Demarez JP.

Arch Pediatr. 2015 Sep;22(9):983-8. doi: 10.1016/j.arcped.2015.06.013. Epub 2015 Jul 27. Review. French.

PMID:
26228811
32.

[Consent in children: Practical situations (part 2)].

Nacka F, Benadjaoud L, Fayon M, Jacqz-Aigrain E; \membres du réseau pédiatrique Inserm des centres d'investigations cliniques (CIC), Demarez JP.

Arch Pediatr. 2015 Sep;22(9):989-95. doi: 10.1016/j.arcped.2015.06.010. Epub 2015 Jul 27. French.

PMID:
26228807
33.

Persistent Infection Because of Pandoraea sputorum in a Young Cystic Fibrosis Patient Resistant to Antimicrobial Treatment.

Pugès M, Debelleix S, Fayon M, Mégraud F, Lehours P.

Pediatr Infect Dis J. 2015 Oct;34(10):1135-7. doi: 10.1097/INF.0000000000000843.

PMID:
26176630
34.

Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients.

Barthe C, Nandakumar S, Derlich L, Macey J, Bui S, Fayon M, Crouzet M, Garbay B, Vilain S, Costaglioli P.

Lett Appl Microbiol. 2015 Nov;61(5):423-8. doi: 10.1111/lam.12465. Epub 2015 Sep 21.

35.

Real-life long-term omalizumab therapy in children with severe allergic asthma.

Deschildre A, Marguet C, Langlois C, Pin I, Rittié JL, Derelle J, Abou Taam R, Fayon M, Brouard J, Dubus JC, Siret D, Weiss L, Pouessel G, Beghin L, Just J.

Eur Respir J. 2015 Sep;46(3):856-9. doi: 10.1183/09031936.00008115. Epub 2015 May 28. No abstract available.

36.

[National consensus regarding azithromycin use in cystic fibrosis].

Abely M, Jubin V, Bessaci-Kabouya K, Chiron R, Bui S, Fayon M.

Rev Mal Respir. 2015 Jun;32(6):557-65. doi: 10.1016/j.rmr.2014.10.733. Epub 2015 May 21. Review. French.

PMID:
26003196
37.

An age-wise comparison of human airway smooth muscle proliferative capacity.

Fayon M, Andrieux A, Bara I, Rebola M, Labbé A, Marthan R, Berger P.

PLoS One. 2015 Mar 23;10(3):e0122446. doi: 10.1371/journal.pone.0122446. eCollection 2015.

38.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, Montaudon M, Berger P, Laurent F.

Radiology. 2015 Jul;276(1):258-65. doi: 10.1148/radiol.15141655. Epub 2015 Mar 13. Erratum in: Radiology. 2016 Apr;279(1):328.

PMID:
25768672
39.

[Pitfalls in hemoglobin oxygen saturation measurement: a case of chronic desaturation].

Eguienta S, Martigne L, Dulucq S, Fayon M.

Arch Pediatr. 2015 Apr;22(4):390-2. doi: 10.1016/j.arcped.2015.01.009. Epub 2015 Feb 26. French.

PMID:
25727475
40.

Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.

Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF.

J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5.

41.

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.

Tiddens HA, De Boeck K, Clancy JP, Fayon M, H G M A, Bresnik M, Derchak A, Lewis SA, Oermann CM; ALPINE study investigators.

J Cyst Fibros. 2015 Jan;14(1):111-9. doi: 10.1016/j.jcf.2014.06.003. Epub 2014 Aug 1.

42.

Cystic fibrosis and AA amyloidosis: a survey in the French cystic fibrosis network.

Stankovic Stojanovic K, Hubert D, Leroy S, Dominique S, Grenet D, Colombat M, Clement A, Fayon M, Grateau G.

Amyloid. 2014 Dec;21(4):231-7. doi: 10.3109/13506129.2014.943834. Epub 2014 Jul 23.

PMID:
25054230
43.

[Viral epidemiology and clinical severity during the peak of the influenza A(H1N1) variant epidemic in febrile respiratory diseases of children].

Feret V, Naud J, Harambat J, Malato L, Fleury H, Fayon M.

Arch Pediatr. 2014 Jul;21(7):709-15. doi: 10.1016/j.arcped.2014.04.017. Epub 2014 Jun 16. French.

PMID:
24947110
44.

[Recommendations for the use of diagnostic testing in low respiratory infections in children older than three months].

Houdouin V, Pouessel G, Angoulvant F, Brouard J, Derelle J, Fayon M, Ferroni A, Gangneux JP, Hau I, Le Bourgeois M, Lorrot M, Menotti J, Nathan N, Vabret A, Wallet F, Bonacorsi S, Cohen R, de Blic J, Deschildre A, Gandemer V, Pin I, Labbe A, Le Roux P, Martinot A, Rammaert B; Groupe de recherche sur les avancées en pneumo-pédiatrie (GRAPP), Dubus JC, Delacourt C, Marguet C.

Arch Pediatr. 2014 Apr;21(4):418-23. doi: 10.1016/j.arcped.2014.01.004. Epub 2014 Mar 7. French. Erratum in: Arch Pediatr. 2014 Aug;21(8):905. Rammaert, S [corrected to Rammaert, B].

PMID:
24613479
45.

Idiopathic eosinophilic pneumonia in children: the French experience.

Giovannini-Chami L, Hadchouel A, Nathan N, Brémont F, Dubus JC, Fayon M, Houdouin V, Berlioz-Baudoin M, Feret V, Leblanc T, Morelle K, Albertini M, Clement A, de Blic J; French Respirare® Group.

Orphanet J Rare Dis. 2014 Feb 20;9:28. doi: 10.1186/1750-1172-9-28.

46.

[National consensus regarding the prescription of inhaled corticosteroids in cystic fibrosis].

Fayon M, Corvol H, Chiron R, Bui S; le Groupe de travail inflammation de la Société française de la mucoviscidose.

Arch Pediatr. 2014 Jan;21(1):88-94. doi: 10.1016/j.arcped.2013.10.016. Epub 2013 Dec 3. French.

PMID:
24309202
47.

New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.

Taytard J, Nathan N, de Blic J, Fayon M, Epaud R, Deschildre A, Troussier F, Lubrano M, Chiron R, Reix P, Cros P, Mahloul M, Michon D, Clement A, Corvol H; French RespiRare® group.

Orphanet J Rare Dis. 2013 Oct 14;8:161. doi: 10.1186/1750-1172-8-161.

48.

Selection of Pseudomonas aeruginosa reference genes for RT-qPCR analysis from sputum of cystic fibrosis patients.

Costaglioli P, Barthe C, Fayon M, Christoflour N, Bui S, Derlich L, Domblides P, Crouzet M, Vilain S, Garbay B.

Mol Cell Probes. 2014 Feb;28(1):10-2. doi: 10.1016/j.mcp.2013.09.003. Epub 2013 Sep 25.

PMID:
24075879
49.

Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.

Bébéar C, Raherison C, Nacka F, de Barbeyrac B, Pereyre S, Renaudin H, Girodet PO, Marquant F, Desjardins S, Chêne G, Fayon M.

Pediatr Infect Dis J. 2014 Mar;33(3):e71-5. doi: 10.1097/INF.0000000000000063.

PMID:
24030350
50.

Pulmonary outcome and its correlates in school-aged children born with a gestational age ≤ 32 weeks.

Choukroun ML, Feghali H, Vautrat S, Marquant F, Nacka F, Leroy V, Demarquez JL, Fayon MJ.

Respir Med. 2013 Dec;107(12):1966-76. doi: 10.1016/j.rmed.2013.06.020. Epub 2013 Jul 20.

Supplemental Content

Support Center